Conversations around AI can often either seem very futuristic, or centre around whether tools such as ChatGPT can be trusted to write an email to your boss.
What is less acknowledged is the way in which it has already begun to transform the drug development process.
From drug design to biomarker identification, many companies are leveraging the power of AI to accelerate medical breakthroughs and bring life-saving drugs and therapies to patients faster.
Check out the rest of the feature here
